A-Series A3/A5 Anesthesia Delivery System; Model Numbers: 0633F-01000-0X (A3) and 0631F-01000-0X ...

FDA Device Recall #Z-0846-2018 — Class II — July 14, 2017

Recall Summary

Recall Number Z-0846-2018
Classification Class II — Moderate risk
Date Initiated July 14, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Mindray DS USA, Inc. dba Mindray North America
Location Mahwah, NJ
Product Type Devices
Quantity 2875 in total

Product Description

A-Series A3/A5 Anesthesia Delivery System; Model Numbers: 0633F-01000-0X (A3) and 0631F-01000-0X (A5) Product Usage: The A-Series Anesthesia System is a device used to administer to a patient, continuously or intermittently, a general inhalation anesthetic, and to maintain a patient s ventilation. The A-Series is intended for use by licensed clinicians, for patients requiring anesthesia within a health care facility, and can be used for adult, pediatric, and infant populations.

Reason for Recall

A software issue may result in the previous settings being applied instead of the default settings or the unit may skip the startup leak test.

Distribution Pattern

Worldwide Distribution - US Nationwide

Lot / Code Information

Units distributed or upgraded between March 2013 and December 21, 2016. Serial numbers requested.

Other Recalls from Mindray DS USA, Inc. dba Mindray Nort...

Recall # Classification Product Date
Z-0920-2026 Class II Hardware configuration of the BeneVision Centra... Nov 18, 2025
Z-0720-2026 Class II Sevoflurane (SEVO) V90 Electronic Vaporizer wit... Oct 20, 2025
Z-0721-2026 Class II Isoflurane (ISO) V90 Electronic Vaporizer with ... Oct 20, 2025
Z-2622-2025 Class II BeneVision N1 Patient Monitor (N1). Part Number... Aug 15, 2025
Z-2951-2024 Class II Isoflurane E_Vap.(Safety Filling adapter): used... Jul 22, 2024

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.